Related references
Note: Only part of the references are listed.1058PDA PHASE I MULTI-ARM DOSE-EXPANSION STUDY OF THE ANTI-PROGRAMMED CELL DEATH-LIGAND-1 (PD-L1) ANTIBODY MEDI4736: PRELIMINARY DATA
N.H. Segal et al.
ANNALS OF ONCOLOGY (2017)
Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes
Muttiah Barathan et al.
APOPTOSIS (2015)
TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
Yinan Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Liver inflammation abrogates immunological tolerance induced by Kupffer cells
Felix Heymann et al.
HEPATOLOGY (2015)
CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice
Yunching Chen et al.
HEPATOLOGY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C
Solomon Owusu Sekyere et al.
JOURNAL OF HEPATOLOGY (2015)
Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice
Mm Li et al.
JOURNAL OF IMMUNOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Immune Response Regulation in the Tumor Microenvironment by Hypoxia
Sara Labiano et al.
SEMINARS IN ONCOLOGY (2015)
T-cell exhaustion in the tumor microenvironment
Y. Jiang et al.
CELL DEATH & DISEASE (2015)
Treating Advanced Hepatocellular Carcinoma: How To Get Out of First Gear
James J. Harding et al.
CANCER (2014)
Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma
Yanmei Han et al.
HEPATOLOGY (2014)
Immunodominance and Functional Alterations of Tumor-Associated Antigen-Specific CD8+ T-Cell Responses in Hepatocellular Carcinoma
Tobias Flecken et al.
HEPATOLOGY (2014)
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
Mei-Ling Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer
Vanessa Gauttier et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Restoration of HBV-specific CD8+T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
Bertram Bengsch et al.
JOURNAL OF HEPATOLOGY (2014)
Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients
Lisa H. Butterfield et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Sowmya Ravi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Phenotypic models of T cell activation
Melissa Lever et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma
Roniel Cabrera et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
Combined Immunostimulatory Monoclonal Antibodies Extend Survival in an Aggressive Transgenic Hepatocellular Carcinoma Mouse Model
Aizea Morales-Kastresana et al.
CLINICAL CANCER RESEARCH (2013)
Combining cancer immunotherapy and targeted therapy
Antoni Ribas et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Activated tumor-infiltrating CD4+regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer
Alexander Pedroza-Gonzalez et al.
HEPATOLOGY (2013)
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
Martin Franz Sprinzl et al.
HEPATOLOGY (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
Ipilimumab Administration in Patients With Advanced Melanoma and Hepatitis B and C
Anupa Sharma et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Ipilimumab-Induced Hepatitis C Viral Suppression
Steven Minter et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
David Gardiner et al.
PLOS ONE (2013)
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma
Masato Abei et al.
RADIATION ONCOLOGY (2013)
KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma
Elisabetta Cariani et al.
ONCOIMMUNOLOGY (2013)
Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
Li-Tzong Chen et al.
ANNALS OF SURGERY (2012)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Altered Functions of Plasmacytoid Dendritic Cells and Reduced Cytolytic Activity of Natural Killer Cells in Patients With Chronic HBV Infection
Jeremie Martinet et al.
GASTROENTEROLOGY (2012)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma
Elisabetta Cariani et al.
PLOS ONE (2012)
PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
Horng-Tay Tzeng et al.
PLOS ONE (2012)
Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
Gaia Nebbia et al.
PLOS ONE (2012)
An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma
David J. Pinato et al.
TRANSLATIONAL RESEARCH (2012)
The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
Asis Palazon et al.
CANCER DISCOVERY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma
Yunhong Xia et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Expansion of interferon-gamma-producing multifunctional CD4+T-cells and dysfunctional CD8+T-cells by glypican-3 peptide library in hepatocellular carcinoma patients
Yanhui Xu et al.
CLINICAL IMMUNOLOGY (2011)
Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C
Jordi Bruix et al.
GASTROENTEROLOGY (2011)
Role of the Coinhibitory Receptor Cytotoxic T Lymphocyte Antigen-4 on Apoptosis-Prone CD8 T Cells in Persistent Hepatitis B Virus Infection
Anna Schurich et al.
HEPATOLOGY (2011)
Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma
Zhen Zeng et al.
PLOS ONE (2011)
Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma
Bao-Ju Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
Tim F. Greten et al.
BMC CANCER (2010)
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
Paola Fisicaro et al.
GASTROENTEROLOGY (2010)
Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses
H. H. Zhang et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Antigen-presenting cell function in the tolerogenic liver environment
Angus W. Thomson et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
C. Alfaro et al.
BRITISH JOURNAL OF CANCER (2009)
Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
Ke Wu et al.
CANCER RESEARCH (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
A Phase II Study of Adoptive Immunotherapy Using Dendritic Cells Pulsed with Tumor Lysate in Patients with Hepatocellular Carcinoma
Daniel H. Palmer et al.
HEPATOLOGY (2009)
Chronically Inflamed Livers Up-Regulate Expression of Inhibitory B7 Family Members
Rachel Kassel et al.
HEPATOLOGY (2009)
Cell-Intrinsic Transforming Growth Factor-β Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence In Vivo
Roberto Tinoco et al.
IMMUNITY (2009)
Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
Dong-Ming Kuang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Regulatory T cells and viral liver disease
Nadia Alatrakchi et al.
JOURNAL OF VIRAL HEPATITIS (2009)
MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib
Roland Houben et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade
Nobuhiro Nakamoto et al.
PLOS PATHOGENS (2009)
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
Madeleine M. Hipp et al.
BLOOD (2008)
Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis
Toshiki Sera et al.
EUROPEAN JOURNAL OF CANCER (2008)
Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells
Frank A. Schildberg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization
Nobuhiro Nakamoto et al.
GASTROENTEROLOGY (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
Qiang You et al.
HEPATOLOGY (2008)
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
Byeong-Ho Park et al.
LANCET ONCOLOGY (2008)
Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation
W. Zhao et al.
LEUKEMIA (2008)
Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8(+) T cell tolerance
Linda Diehl et al.
HEPATOLOGY (2008)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma
Chung Mau Lo et al.
ANNALS OF SURGERY (2007)
Unmasking of α-fetoprotein-specific CD4+ T cell responses in hepatocellular carcinoma patients undergoing embolization
Lakshmana Ayaru et al.
JOURNAL OF IMMUNOLOGY (2007)
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Vincenzo Mazzaferro et al.
HEPATOLOGY (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B1
Dongping Xu et al.
JOURNAL OF IMMUNOLOGY (2006)
Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma:: a randomized clinical trial
Hui-Chuan Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Hierarchy of a fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer
Yang Liu et al.
JOURNAL OF IMMUNOLOGY (2006)
Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma
Eishiro Mizukoshi et al.
HEPATOLOGY (2006)
Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses
Olivier Adotevi et al.
CLINICAL CANCER RESEARCH (2006)
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells - A clinical trial
WC Lee et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition
VG Pillarisetty et al.
JOURNAL OF IMMUNOLOGY (2004)
Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors
SM Lin et al.
CANCER (2004)
Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma
K Fujiwara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma
F Korangy et al.
CLINICAL CANCER RESEARCH (2004)
An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection
R Cabrera et al.
HEPATOLOGY (2004)
Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma
A Zerbini et al.
JOURNAL OF HEPATOLOGY (2004)
Downregulation of the proteasome subunits, transporter, and antigen presentation in hepatocellular carcinoma, and their restoration by interferon-γ
M Matsui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection
S Reignat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy
S Kubo et al.
BRITISH JOURNAL OF SURGERY (2002)
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
A Limmer et al.
NATURE MEDICINE (2000)
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
JM Llovet et al.
HEPATOLOGY (2000)
Share Paper
